GoodRx Holdings, Inc.GDRXEarnings & Financial Report
GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx compares prescription drug prices at more than 75,000 pharmacies in the United States. The platform allows users to consult a doctor online and obtain a prescription for certain types of medications.
Revenue
$203.1M
Gross Profit
N/A
Operating Profit
$26.8M
Net Profit
$12.8M
Gross Margin
N/A
Operating Margin
13.2%
Net Margin
6.3%
YoY Growth
1.2%
EPS
$0.04
Financial Flow
GoodRx Holdings, Inc. Q2 2025 Financial Summary
GoodRx Holdings, Inc. reported revenue of $203.1M (up 1.2% YoY) for Q2 2025, with a net profit of $12.8M (up 91.9% YoY) (6.3% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $203.1M |
|---|---|
| Net Profit | $12.8M |
| Gross Margin | N/A |
| Operating Margin | 13.2% |
| Report Period | Q2 2025 |
Revenue Breakdown
GoodRx Holdings, Inc. Q2 2025 revenue of $203.1M breaks down across 4 segments, led by Prescription Transactions Revenue at $143.1M (70.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Prescription Transactions Revenue | $143.1M | 70.5% |
| Pharma Manufacturer Solutions Revenues | $35.0M | 17.2% |
| Subscription Revenue | $20.5M | 10.1% |
| Other Revenue | $4.6M | 2.2% |
GoodRx Holdings, Inc. Revenue by Segment — Quarterly Trend
GoodRx Holdings, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Prescription Transactions Revenue and Pharma Manufacturer Solutions Revenues) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Prescription Transactions Revenue | $124.7M | $127.3M | $143.1M | $148.9M |
| Pharma Manufacturer Solutions Revenues | — | $43.4M | $35.0M | $28.6M |
| Subscription Revenue | $21.6M | $20.7M | $20.5M | $21.0M |
| Other Revenue | $4.1M | $4.6M | $4.6M | $4.4M |
GoodRx Holdings, Inc. Annual Revenue by Year
GoodRx Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $796.9M).
| Year | Annual Revenue |
|---|---|
| 2025 | $796.9M |
| 2024 | $792.3M |
| 2023 | $750.3M |
| 2022 | $766.6M |
GoodRx Holdings, Inc. Quarterly Revenue & Net Profit History
GoodRx Holdings, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $194.8M | -1.9% | $5.4M | 2.8% |
| Q3 2025 | $196.0M | +0.4% | $1.1M | 0.6% |
| Q2 2025 | $203.1M | +1.2% | $12.8M | 6.3% |
| Q1 2025 | $203.0M | +2.6% | $11.1M | 5.4% |
| Q4 2024 | $198.6M | +1.0% | $6.7M | 3.4% |
| Q3 2024 | $195.3M | +8.5% | $4.0M | 2.0% |
| Q2 2024 | $200.6M | +5.8% | $6.7M | 3.3% |
| Q1 2024 | $197.9M | +7.6% | $-1.0M | -0.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $197.9M | $200.6M | $195.3M | $198.6M | $203.0M | $203.1M | $196.0M | $194.8M |
| YoY Growth | 7.6% | 5.8% | 8.5% | 1.0% | 2.6% | 1.2% | 0.4% | -1.9% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.45B | $1.48B | $1.35B | $1.39B | $1.30B | $1.32B | $1.33B | $1.40B |
| Liabilities | $822.9M | $806.0M | $658.4M | $663.4M | $640.9M | $675.7M | $724.8M | $787.8M |
| Equity | $631.1M | $669.4M | $696.4M | $724.7M | $654.3M | $643.0M | $600.7M | $616.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $42.6M | $9.7M | $86.9M | $44.7M | $9.4M | $49.6M | $76.0M | $32.9M |